MARKET RADAR
SENSEX     NIFTY      Refresh
Ranbaxy Laboratories Consolidated Profit & Loss account, Ranbaxy Laboratories Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Consolidated Profit & Loss account - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 29, 14:53
539.00
14.3 (2.73%)
VOLUME 324,109
LIVE
NSE
May 29, 14:54
538.70
13.5 (2.57%)
VOLUME 1,593,656

Consolidated Profit & Loss account of Ranbaxy Laboratories

------------------- in Rs. Cr. -------------------
Dec '10 Dec '09 Dec '08 Dec '07 Dec '06
12 mths 12 mths 12 mths 12 mths 12 mths
Income
Sales Turnover 8,962.30 7,611.77 7,475.33 6,825.67 6,180.71
Excise Duty 40.96 15.90 55.85 51.37 53.86
Net Sales 8,921.34 7,595.87 7,419.48 6,774.30 6,126.85
Other Income 1,015.37 535.75 -1,648.92 581.16 55.82
Stock Adjustments 313.74 -111.04 174.60 10.61 162.79
Total Income 10,250.45 8,020.58 5,945.16 7,366.07 6,345.46
Expenditure
Raw Materials 3,443.33 3,098.26 3,282.88 2,792.44 2,587.19
Power & Fuel Cost 200.50 165.78 120.43 97.37 85.07
Employee Cost 1,505.98 1,417.47 966.58 890.27 792.89
Other Manufacturing Expenses 138.64 140.10 282.95 167.51 164.64
Selling and Admin Expenses 1,580.40 1,546.90 1,877.47 1,789.80 1,578.02
Miscellaneous Expenses 496.64 389.51 445.48 261.77 204.16
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,365.49 6,758.02 6,975.79 5,999.16 5,411.97
Dec '10 Dec '09 Dec '08 Dec '07 Dec '06
12 mths 12 mths 12 mths 12 mths 12 mths
Operating Profit 1,869.59 726.81 618.29 785.75 877.67
PBDIT 2,884.96 1,262.56 -1,030.63 1,366.91 933.49
Interest 61.39 71.04 205.50 141.19 103.63
PBDT 2,823.57 1,191.52 -1,236.13 1,225.72 829.86
Depreciation 553.27 267.61 282.47 175.20 149.44
Other Written Off 0.00 0.00 0.38 44.71 37.48
Profit Before Tax 2,270.30 923.91 -1,518.98 1,005.81 642.94
Extra-ordinary items 58.56 85.64 17.87 23.01 23.91
PBT (Post Extra-ord Items) 2,328.86 1,009.55 -1,501.11 1,028.82 666.85
Tax 582.99 698.07 -564.96 211.89 135.67
Reported Net Profit 1,736.85 310.68 -934.95 786.65 515.36
Minority Interest 12.56 10.95 8.44 12.37 5.02
Share Of P/L Of Associates 227.54 3.24 7.82 -0.21 0.00
Net P/L After Minority Interest & Share Of Associates 1,438.20 210.86 -969.07 751.58 501.23
Total Value Addition 3,922.16 3,659.76 3,692.91 3,206.71 2,824.77
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Equity Dividend 84.21 0.00 0.00 317.16 316.89
Corporate Dividend Tax 13.99 0.00 0.00 53.90 44.44
Per share data (annualised)
Shares in issue (lakhs) 4,210.41 4,204.18 4,203.70 3,730.71 3,726.87
Earning Per Share (Rs) 41.25 7.39 -22.24 21.09 13.83
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00
Book Value (Rs) 132.80 98.96 97.58 74.61 68.85
Source : Dion Global Solutions Limited
Quick Links for ranbaxylaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.